Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.99 USD | +3.48% | +18.43% | 0.00% |
Apr. 22 | Guggenheim Starts Coverage on Boundless Bio With Buy Rating, $24 Price Target | MT |
Apr. 22 | Piper Sandler Starts Audentes Therapeutics With Overweight Rating, $20 Price Target | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Neutral | Neutral |
Resistance | 12.07 | 13.62 | 11.64 |
Spread/Res. | -8.95% | -19.31% | -5.58% |
Spread/Supp. | +27.94% | +27.94% | +27.94% |
Support | 8.590 | 8.590 | 8.590 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- BOLD Stock
- Charts Boundless Bio, Inc.